Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
Digital decision support and remote patient monitoring may improve outcomes and efficiency, but rarely scale beyond a single institution. Over the last 5 years, the platform Timely Interventions for Diabetes Excellence (TIDE) has been…
Continue Reading
What You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue Reading
– A recent study has shed light on the significant potential of the ECHO Model in improving diabetes care in rural communities.
– The research, published in The Journal of General Internal Medicine, showed that…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.
– This marks a significant advancement in diabetes management, offering a fully-implantable, long-term…
Continue Reading
Historically, the medical devices world has been a highly proprietary industry, having long been characterized by the development of specialized, patented technologies that are closely guarded by their creators. You won’t find an App…
Continue Reading
Abbott and Medtronic are typically regarded as competitors, but the two medical device giants have recently decided to join forces.
Last week, the two companies teamed up to collaborate on a continuous glucose monitoring (CGM)…
Continue Reading
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom’s G7 and G6 continuous glucose monitoring (CGM) systems, has been cleared for sale by Health Canada, the department…
Continue Reading
What You Should Know:
– Tandem Diabetes Care announced today that its Tandem Mobi insulin pump is fully compatible with Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) systems.
– Tandem is now the only…
Continue Reading
Tony Vahedian, CEO at CCS
A report from the Peterson Health Technology Institute (PHTI) found that many digital diabetes management platforms aren’t providing meaningful ROI for patients or the health system as a whole. Users of common…
Continue Reading
